Name | Ethyl N-[2-(3-pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3- yl)-4-pyrimidinyl]-β-alaninate |
---|---|
Synonyms |
β-Alanine, N-[2-(3-pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-, ethyl ester
Ethyl N-[2-(3-pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alaninate |
Description | GSK-J5 is a potent inhibitor of Schistosome and worm. GSK-J5 increases schistosomula mortality and adult worm motility and mortality, as well as egg oviposition, in a dose- and time-dependent manner[1]. |
---|---|
Related Catalog | |
References |
[3]. Heinemann B, et al. Inhibition of demethylases by GSK-J1/J4. Nature. 2014 Oct 2;514(7520):E1-2 |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 581.2±50.0 °C at 760 mmHg |
Molecular Formula | C24H27N5O2 |
Molecular Weight | 417.50 |
Flash Point | 305.3±30.1 °C |
Exact Mass | 417.216461 |
PSA | 80.24000 |
LogP | 3.75 |
Vapour Pressure | 0.0±1.6 mmHg at 25°C |
Index of Refraction | 1.615 |